Company Filing History:
Years Active: 1984
Title: The Innovative Mind of Agris Z. Skuya
Introduction
Agris Z. Skuya is a notable inventor based in Riga, Latvia, recognized for his contributions to the field of biomedical engineering. His innovative approach to creating polysaccharide derivatives has the potential to advance medical treatments.
Latest Patents
Skuya holds a patent for a "Dextran derivative of fibrinolysin," which details a method of preparing a polysaccharide derivative of fibrinolysin. This method involves reacting fibrinolysin with dextran dialdehyde, possessing a molecular mass between 20,000 and 110,000. The process occurs at a pH ranging from 8.0 to 9.5 and a temperature between 5 to 30 degrees Celsius, leading to the formation of a covalent bond. Following this reaction, the resulting fibrinolysin derivative undergoes reduction with sodium borohydride for isolation.
Career Highlights
Agris Z. Skuya is affiliated with the All-Union Cardiology Research Center, where he applies his expertise in biochemistry and pharmaceuticals. His work has led to significant advancements in the preparation and application of fibrinolytics, which are critical in treating blood clot-related conditions.
Collaborations
Throughout his career, Skuya has collaborated with esteemed colleagues, including Evgeny I. Chazov and Vladimir N. Smirnov. These partnerships have facilitated the sharing of knowledge and resources, enhancing research efforts in cardiovascular treatments.
Conclusion
Agris Z. Skuya exemplifies the spirit of innovation through his significant contributions to the field of medical science. His patent and collaborative work continue to influence the development of advanced therapeutic solutions, highlighting the impact of inventive minds in healthcare.